Home/Filings/4/0001062993-23-017516
4//SEC Filing

Olds Donald 4

Accession 0001062993-23-017516

CIK 0001444192other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 3:54 PM ET

Size

5.7 KB

Accession

0001062993-23-017516

Insider Transaction Report

Form 4
Period: 2023-08-31
Olds Donald
Director
Transactions
  • Purchase

    Common Shares

    2023-08-31$2.05/sh+381$781381 total
Holdings
  • Common Shares

    (indirect: By Spouse)
    792
Footnotes (2)
  • [F1]These indirect holdings have been adjusted to give effect to the Company's 1-for-8 reverse stock split, effective August 31, 2021, and the Company's 1-for-6 reverse stock split, effective July 10, 2023.
  • [F2]792 common shares held by Mr. Olds' wife, Ofra Aslan. Mr. Olds disclaims beneficial ownership of the common shares held by his wife and this report shall not be deemed an admission that Mr. Olds is a beneficial owner of such for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Issuer

Acasti Pharma Inc.

CIK 0001444192

Entity typeother

Related Parties

1
  • filerCIK 0001807762

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 3:54 PM ET
Size
5.7 KB